Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

937
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
937
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

478
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
478
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

838
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
838
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

540
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
540
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting antimicrobial resistance for precision medicine.

Cell host & microbe·2026
Same author

HIV drug resistance and treatment success in the Republic of Congo: Implications for optimized treatment.

HIV medicine·2026
Same author

Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.

The Lancet. Oncology·2026
Same author

Persistent Gut-Immune Axis dysregulation in long-term Post-COVID Syndrome: Insights from a prospective, observational, cross-sectional case-control study.

Mucosal immunology·2026
Same author

Towards selective peptide deformylase inhibitors: A mass spectrometry-based evaluation of in cellulo activity of actinonin and bromoindole derivatives.

European journal of medicinal chemistry·2026
Same author

Host- and pathogen-related determinants of pulmonary <i>versus</i> extrapulmonary tuberculosis.

European respiratory review : an official journal of the European Respiratory Society·2026

Related Experiment Video

Updated: Jan 16, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.2K

[Extrapulmonary tuberculosis].

Angela Klingmüller1, Jonathan Steinke1, Jan Rybniker1

  • 1Klinische Infektiologie, Medizinische Klinik I, Köln.

Deutsche Medizinische Wochenschrift (1946)
|September 29, 2025
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) remains a global threat, with rising cases in Germany due to migration. Extrapulmonary TB (EPTB) is challenging to diagnose, highlighting the need for better diagnostic tools.

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.8K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.1K

Related Experiment Videos

Last Updated: Jan 16, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.2K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.8K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.1K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Microbiology

Background:

  • Tuberculosis (TB) remains the world's deadliest infectious disease, causing 1.25 million deaths in 2023.
  • Germany has seen a slight increase in TB incidence in 2022-2023, primarily linked to migration.
  • Extrapulmonary TB (EPTB) accounts for 22.8% of cases, presenting diagnostic challenges due to nonspecific symptoms.

Purpose of the Study:

  • To review the current landscape of tuberculosis diagnosis and treatment.
  • To highlight the challenges in diagnosing extrapulmonary TB.
  • To emphasize the urgent need for improved diagnostic markers for TB treatment response.

Main Methods:

  • Review of global and German TB incidence data.
  • Analysis of extrapulmonary TB prevalence and diagnostic difficulties.
  • Summary of current diagnostic methods (microscopy, PCR, culture) and treatment protocols.
  • Discussion of treatment response assessment and limitations.

Main Results:

  • TB incidence is rising globally and in Germany, influenced by migration.
  • Extrapulmonary TB (EPTB) is a significant proportion of cases and is difficult to diagnose.
  • Current diagnostic and treatment monitoring methods have limitations.

Conclusions:

  • Tuberculosis continues to be a major global health concern.
  • Diagnosing extrapulmonary TB requires improved strategies.
  • Development of reliable blood-based markers for monitoring TB treatment response is critical.